These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 16034467)

  • 1. Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis.
    Akiyama T; Matsunaga T; Terui T; Miyanishi K; Tanaka I; Sato T; Kuroda H; Takimoto R; Takayama T; Kato J; Yamauchi N; Kogawa K; Sakamaki S; Hirayama Y; Kohda K; Niitsu Y
    Leukemia; 2005 Sep; 19(9):1558-66. PubMed ID: 16034467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
    Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
    J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of clinical features and prognosis of primary myelodysplastic syndromes with myelofibrosis patients].
    Su T; Zhang PH; Xu ZF; Chen HS; Qin TJ; Zhang Y; Zhang HL; Fan LW; Pan LJ; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):378-82. PubMed ID: 22781796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow histochemical studies of fibrogenic cytokines and their receptors in myelodysplastic syndrome with myelofibrosis and related disorders.
    Yoon SY; Li CY; Lloyd RV; Tefferi A
    Int J Hematol; 2000 Oct; 72(3):337-42. PubMed ID: 11185990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor β- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow.
    Nakayama S; Yokote T; Hiraoka N; Akioka T; Nishiwaki U; Miyoshi T; Iwaki K; Fumimoto A; Masuda Y; Hatooka J; Fujimoto M; Nishimura Y; Tsuji M
    Hum Pathol; 2017 Apr; 62():180-186. PubMed ID: 28159675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
    Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
    Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes.
    Hou M; Andersson PO; Stockelberg D; Mellqvist UH; Ridell B; Wadenvik H
    Br J Haematol; 1998 Jun; 101(3):420-4. PubMed ID: 9633881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia.
    Shehata M; Schwarzmeier JD; Hilgarth M; Hubmann R; Duechler M; Gisslinger H
    J Clin Invest; 2004 Mar; 113(5):676-85. PubMed ID: 14991065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of thrombopoietin on proliferation of blasts from patients with myelodysplastic syndromes.
    Luo SS; Ogata K; Yokose N; Kato T; Dan K
    Stem Cells; 2000; 18(2):112-9. PubMed ID: 10742383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis.
    Bae E; Park CJ; Cho YU; Seo EJ; Chi HS; Jang S; Lee KH; Lee JH; Lee JH; Suh JJ; Im HJ
    Int J Lab Hematol; 2013 Dec; 35(6):629-36. PubMed ID: 23693053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxy-terminal fragment of osteogenic growth peptide in vitro increases bone marrow cell density in idiopathic myelofibrosis.
    Fazzi R; Pacini S; Testi R; Azzarà A; Galimberti S; Testi C; Trombi L; Metelli MR; Petrini M
    Br J Haematol; 2003 Apr; 121(1):76-85. PubMed ID: 12670334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte/macrophage dysfunctions do not impair the promotion of myelofibrosis by high levels of thrombopoietin.
    Wagner-Ballon O; Chagraoui H; Prina E; Tulliez M; Milon G; Raslova H; Villeval JL; Vainchenker W; Giraudier S
    J Immunol; 2006 Jun; 176(11):6425-33. PubMed ID: 16709799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients.
    Maschek H; Georgii A; Kaloutsi V; Werner M; Bandecar K; Kressel MG; Choritz H; Freund M; Hufnagl D
    Eur J Haematol; 1992 Apr; 48(4):208-14. PubMed ID: 1592101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up.
    Thiele J; Kvasnicka HM; Zerhusen G; Vardiman J; Diehl V; Luebbert M; Schmitt-Graeff A
    Ann Hematol; 2004 Aug; 83(8):513-21. PubMed ID: 15173958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta1 (TGF-beta1) induces thrombopoietin from bone marrow stromal cells, which stimulates the expression of TGF-beta receptor on megakaryocytes and, in turn, renders them susceptible to suppression by TGF-beta itself with high specificity.
    Sakamaki S; Hirayama Y; Matsunaga T; Kuroda H; Kusakabe T; Akiyama T; Konuma Y; Sasaki K; Tsuji N; Okamoto T; Kobune M; Kogawa K; Kato J; Takimoto R; Koyama R; Niitsu Y
    Blood; 1999 Sep; 94(6):1961-70. PubMed ID: 10477725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired megakaryopoiesis in patients with chronic idiopathic neutropenia is associated with increased transforming growth factor beta1 production in the bone marrow.
    Psyllaki M; Damianaki A; Gemetzi C; Pyrovolaki K; Eliopoulos GD; Papadaki HA
    Br J Haematol; 2006 Sep; 134(6):624-31. PubMed ID: 16938119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis.
    Ciurea SO; Merchant D; Mahmud N; Ishii T; Zhao Y; Hu W; Bruno E; Barosi G; Xu M; Hoffman R
    Blood; 2007 Aug; 110(3):986-93. PubMed ID: 17473062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profile of inflammatory and megakaryocytic factors in pediatric myelodysplastic syndrome with acute myelofibrosis.
    Hussein K; Suttorp M; Stucki-Koch A; Baumann I; Niemeyer CM; Kreipe H
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27048. PubMed ID: 29667765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes.
    Maratheftis CI; Andreakos E; Moutsopoulos HM; Voulgarelis M
    Clin Cancer Res; 2007 Feb; 13(4):1154-60. PubMed ID: 17317824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.